Advertisement

Cancer Causes & Control

, Volume 23, Issue 4, pp 617–623 | Cite as

Asthma and risk of brain cancer in children

  • Federico Roncarolo
  • Claire Infante-RivardEmail author
Original paper

Abstract

Purpose

Little is known about the causes of central nervous system tumors in children. An inverse association between asthma and brain cancer was found in adults, but there is a dearth of studies in children. The goal of this study was to evaluate the association between asthma and brain cancer in children.

Methods

Two hundred and seventy-two cases of children with brain tumor diagnosed between 0 and 14 years of age in the Province of Québec, Canada, between 1980 and 1999 and 272 incidence density-matched controls were included in the study. The parents of cases and controls were interviewed by phone using structured questionnaires. Besides asthma in children, family history of asthma, the presence of other atopies, and medication intake were also investigated. Conditional logistic regression was used to analyze the data.

Results

Brain tumor risk was decreased in children with asthma (OR, 0.55; CI 95%, 0.33–0.93), with eczema (OR, 0.52; CI 95%, 0.17–1.57), and with both asthma and eczema (OR, 0.76; CI 95%, 0.18–3.2). Maternal or sibling asthma did not modify the effect of asthma on central nervous system (CNS) tumors, while father’s asthma seemed to increase the risk, but numbers were small. Antiasthma medications such as inhaled corticosteroid and beta agonists seemed to increase the risk of CNS tumors (OR for steroids, 2.55; CI 95%, 0.79–8.20 and OR for inhaled beta agonist, 1.62; CI 95%, 0.57–4.63).

Conclusions

This study strengthens the hypothesis of inverse association between asthma and brain cancer in children, but family history and medications for asthma need further investigation.

Keywords

Child Brain cancer Asthma Asthma medication 

Notes

Acknowledgments

The project was supported in part by The Brain Tumor Foundation of Canada. The authors wish to thank M. Alexandre Cusson for programming assistance. FR is a postdoctoral fellow in the Department of Epidemiology, Biostatistics and Occupational Health, McGill University and was supported by the Associazione Italiana lotta contro le Leucemie, Linfomi e Mielomi, sede Torino. CIR is a James McGill Professorship (Canada Research Chair).

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    Anonymous (2003) Diagnosis and initial treatment of cancer in Canadian children 0 to 14 years, 1995–2000. Health, Canada, OttawaGoogle Scholar
  2. 2.
    McKinney P (2005) Central nervous system tumours in children: epidemiology and risk factors. Bioelectromagnetics Suppl 7:S60–S68PubMedCrossRefGoogle Scholar
  3. 3.
    Linet M, Wacholder S, Zahm S (2003) Interpreting epidemiologic research: lessons from studies of childhood cancer. Pediatrics 112(1 Pt 2):218–232PubMedGoogle Scholar
  4. 4.
    Filippini G, Maisonneuve P, McCredie M, Peris-Bonet R, Modan B, Preston-Martin S, Mueller B, Holly E, Cordier S, Choi N, Little J, Arslan A, Boyle P (2002) Relation of childhood brain tumors to exposure of parents and children to tobacco smoke: the search international case-control study. Int J Cancer 100(2):206–213PubMedCrossRefGoogle Scholar
  5. 5.
    Fear N, Roman E, Ansell P, Bull D (2001) Malignant neoplasms of the brain during childhood: the role of prenatal and neonatal factors (United Kingdom). Cancer Causes Control 12(5):443–449PubMedCrossRefGoogle Scholar
  6. 6.
    Shaw A, Li P, Infante-Rivard C (2006) Early infection and risk of childhood brain tumors (Canada). Cancer Causes Control 17(10):1267–1274PubMedCrossRefGoogle Scholar
  7. 7.
    Huncharek M, Kupelnick B, Klassen H (2002) Maternal smoking during pregnancy and the risk of childhood brain tumors: a meta-analysis of 6566 subjects from twelve epidemiological studies. J Neurooncol 57(1):51–57PubMedCrossRefGoogle Scholar
  8. 8.
    Pogoda J, Preston-Martin S, Howe G, Lubin F, Mueller B, Holly E, Filippini G, Peris-Bonet R, McCredie M, Cordier S, Choi W (2009) An international case-control study of maternal diet during pregnancy and childhood brain tumor risk: a histology-specific analysis by food group. Ann Epidemiol 19(3):148–160PubMedCrossRefGoogle Scholar
  9. 9.
    Preston-Martin S, Pogoda J, Mueller B, Lubin F, Modan B, Holly E, Filippini G, Cordier S, Peris-Bonet R, Won C, Little J, Arslan A (1998) Results from an international case-control study of childhood brain tumors: the role of prenatal vitamin supplementation. Environ Health Perspect 106:887–892PubMedGoogle Scholar
  10. 10.
    Stalberg K, Haglund B, Stromberg B, Kieler H (2010) Prenatal exposure to medicines and the risk of childhood brain tumor. Cancer Epidemiol 34(4):400–404PubMedCrossRefGoogle Scholar
  11. 11.
    Schlehofer B, Blettner M, Preston-Martin S, Niehoff D, Wahrendorf J, Arslan A, Ahlbom A, Choi W, Giles G, Howe G, Little J, Ménégoz F, Ryan P (1999) Role of medical history in brain tumour development. Results from the international adult brain tumour study. Int J Cancer 82(2):155–160PubMedCrossRefGoogle Scholar
  12. 12.
    Brenner A, Linet M, Fine H, Shapiro W, Selker R, Black P, Inskip P (2002) History of allergies and autoimmune diseases and risk of brain tumors in adults. Int J Cancer 99(2):252–259PubMedCrossRefGoogle Scholar
  13. 13.
    Schoemaker M, Swerdlow A, Hepworth S, McKinney P, van Tongeren M, Muir K (2006) History of allergies and risk of glioma in adults. Int J Cancer 119(9):2165–2172PubMedCrossRefGoogle Scholar
  14. 14.
    Berg-Beckhoff G, Schüz J, Blettner M, Münster E, Schlaefer K, Wahrendorf J, Schlehofer B (2009) History of allergic disease and epilepsy and risk of glioma and meningioma (INTERPHONE study group, Germany). Eur J Epidemiol 24(8):433–440PubMedCrossRefGoogle Scholar
  15. 15.
    Wigertz A, Lonn S, Schwartzbaum J, Hall P, Auvinen A, Christensen H, Johansen C, Klaeboe L, Salminen T, Schoemaker M, Swerdlow A, Tynes T, Feychting M (2007) Allergic conditions and brain tumor risk. Am J Epidemiol 166(8):941–950PubMedCrossRefGoogle Scholar
  16. 16.
    Bondy M, Scheurer M, Malmer B, Barnholtz-Sloan J, Davis F, Il’yasova D, Kruchko C, McCarthy B, Rajaraman P, Schwartzbaum J, Sadetzki S, Schlehofer B, Tihan T, Wiemels J, Wrensch M, Buffler P (2008) Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium. Cancer 113(S7):1953–1968PubMedCrossRefGoogle Scholar
  17. 17.
    Dix A, Brooks W, Roszman T, Morford L (1999) Immune defects observed in patients with primary malignant brain tumors. J Neuroimmunol 100(1–2):216–232PubMedCrossRefGoogle Scholar
  18. 18.
    Harding N, Birch J, Hepworth S, McKinney P (2008) Atopic dysfunction and risk of central nervous system tumours in children. Eur J Cancer 44(1):92–99PubMedCrossRefGoogle Scholar
  19. 19.
    Kramarova E, Stiller CA, Ferlay J, Parkin DM (1996) International classification of childhood cancer. IARC technical report. IARC, LyonGoogle Scholar
  20. 20.
    Brooks DR, Mucci LA, Hatch EE, Cnattingius S (2004) Maternal smoking during pregnancy and risk of brain tumors in the offspring. A prospective study of 1.4 million Swedish births. Cancer Causes Control 15(10):997–1005PubMedCrossRefGoogle Scholar
  21. 21.
    Bunin G, Kuijten R, Buckley J, Rorke L, Meadows A (1993) Relation between maternal diet and subsequent primitive neuroectodermal brain tumors in young children. N Engl J Med 329(8):536–541PubMedCrossRefGoogle Scholar
  22. 22.
    Schuz J, Weihkopf T, Kaatsch P (2007) Medication use during pregnancy and the risk of childhood cancer in the offspring. Eur J Pediatr 166(5):433–441PubMedCrossRefGoogle Scholar
  23. 23.
    Gurney J, Smith M, Olshan A, Hecht S, Kasum C (2001) Clues to the etiology of childhood brain cancer: N-nitroso compounds, polyomaviruses, and other factors of interest. Cancer Invest 19(6):630–640PubMedCrossRefGoogle Scholar
  24. 24.
    Burnet M (1957) Cancer: a biological approach. III. Viruses associated with neoplastic conditions. IV. Practical applications. Br Med J 1(5023):841–847PubMedCrossRefGoogle Scholar
  25. 25.
    Dunn G, Bruce A, Ikeda H, Old L, Schreiber R (2002) Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol 3(11):991–998PubMedCrossRefGoogle Scholar
  26. 26.
    Wiemels J, Wiencke J, Patoka J, Moghadassi M, Chew T, McMillan A, Miike R, Barger G, Wrensch M (2004) Reduced immunoglobulin E and allergy among adults with glioma compared with controls. Cancer Res 64(22):8468–8473PubMedCrossRefGoogle Scholar
  27. 27.
    Schwartzbaum J, Ahlbom A, Malmer B, Lönn S, Brookes A, Doss H, Debinski W, Henriksson R, Feychting M (2005) Polymorphisms associated with asthma are inversely related to glioblastoma multiforme. Cancer Res 65(14):6459–6465PubMedCrossRefGoogle Scholar
  28. 28.
    Wiemels J, Wiencke J, Sison J, Miike R, McMillan A, Wrensch M (2002) History of allergies among adults with glioma and controls. Int J Cancer 98(4):609–615PubMedCrossRefGoogle Scholar
  29. 29.
    Linos E, Raine T, Alonso A, Michaud D (2007) Atopy and risk of brain tumors: a meta-analysis. J Natl Cancer Inst 99(20):1544–1550PubMedCrossRefGoogle Scholar
  30. 30.
    Castro-Rodriguez J (2010) The asthma predictive index: a very useful tool for predicting asthma in young children. J Allergy Clin Immunol 126(2):212–216PubMedCrossRefGoogle Scholar
  31. 31.
    Burke W, Fesinmeyer M, Reed K, Hampson L, Carlsten C (2003) Family history as a predictor of asthma risk. Am J Prev Med 24(2):160–169PubMedCrossRefGoogle Scholar
  32. 32.
    Garner R, Cohen D (2008) Changes in the prevalence of asthma among Canadian children. Health Rep 19(2):45–50PubMedGoogle Scholar
  33. 33.
    Wilckens T, De Rijk R (1997) Glucocorticoids and immune function: unknown dimensions and new frontiers. Immunol Today 18(9):418–424PubMedCrossRefGoogle Scholar
  34. 34.
    Lipworth B (1999) Systemic adverse effects of inhaled corticosteroid therapy: a systematic review and meta-analysis. Arch Intern Med 159(9):941–955PubMedCrossRefGoogle Scholar
  35. 35.
    Pekkanen J, Pearce N (1999) Defining asthma in epidemiological studies. Eur Resp J 14(4):951–957CrossRefGoogle Scholar
  36. 36.
    Toren K, Brisman J, Jarvholm B (1993) Asthma and asthma-like symptoms in adults assessed by questionnaires—a literature review. Chest 104(2):600–608PubMedCrossRefGoogle Scholar
  37. 37.
    Toren K, Palmqvist M, Lowhagen O, Balder B, Tunsater A (2006) Self-reported asthma was biased in relation to disease severity while reported year of asthma onset was accurate. J Clin Epidemiol 59(1):90–93PubMedCrossRefGoogle Scholar
  38. 38.
    Remes ST, Pekkanen J, Remes K, Salonen RO, Korppi M (2002) In search of childhood asthma: questionnaire, tests of bronchial hyperresponsiveness, and clinical evaluation. Thorax 57(2):120–126PubMedCrossRefGoogle Scholar
  39. 39.
    De Marco R, Cerveri I, Bugiani M, Ferrari M, Verlato G (1998) An undetected burden of asthma in Italy: the relationship between clinical and epidemiological diagnosis of asthma. Eur Resp J 11(3):599–605Google Scholar
  40. 40.
    Zuidgeest MG, van Dijk L, Smit HA, van der Wouden JC, Brunekreef B, Leufkens HG, Bracke M (2008) Prescription of respiratory medication without an asthma diagnosis in children: a population based study. BMC Health Serv Res 8:16PubMedCrossRefGoogle Scholar
  41. 41.
    Asher M, Montefort S, Bjorksten B, Lai C, Strachan D, Weiland S, Williams H (2006) Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet 368(9537):733–743PubMedCrossRefGoogle Scholar
  42. 42.
    Millar W, Hill G (1998) Childhood asthma. Health Rep Winter 10(3):9–21Google Scholar

Copyright information

© Springer Science+Business Media B.V. 2012

Authors and Affiliations

  1. 1.Department of Epidemiology, Biostatistics and Occupational Health, Faculty of MedicineMcGill UniversityMontréalCanada

Personalised recommendations